Mutations in GATA2 are rare in juvenile myelomonocytic leukemia

Por Stieglitz, Elliot, Liu, Y. Lucy, Emanuel, Peter D., Castleberry, Robert P., Cooper, Todd M., Shannon, Kevin M., Loh, Mignon L.
Publicado em 2014

Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study

Por London, Wendy B., Frantz, Christopher N., Campbell, Laura A., Seeger, Robert C., Brumback, Babette A., Cohn, Susan L., Matthay, Katherine K., Castleberry, Robert P., Diller, Lisa
Publicado em 2010

Detection of MYCN Gene Amplification in Neuroblastoma by Fluorescence In Situ Hybridization: A Pediatric Oncology Group Study

Por Mathew, Prasad, Valentine, Marcus B, Bowman, Laura C, Rowe, Susan T, Nash, Michael B, Valentine, Virginia A, Cohn, Susan L, Castleberry, Robert P, Brodeur, Garrett M, Look, A Thomas
Publicado em 2001

Ocular Late Effects in Childhood and Adolescent Cancer Survivors: A Report from the Childhood Cancer Survivor Study

Por Whelan, Kimberly F., Stratton, Kayla, Kawashima, Toana, Waterbor, John W., Castleberry, Robert P., Stovall, Marilyn, Sklar, Charles A., Packer, Roger J., Mitby, Pauline, Aitken, Candice L., Blatt, Julie, Robison, Leslie L., Mertens, Ann C.
Publicado em 2010

The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease

Por Kratz, Christian P., Niemeyer, Charlotte M., Castleberry, Robert P., Cetin, Mualla, Bergsträsser, Eva, Emanuel, Peter D., Hasle, Henrik, Kardos, Gabriela, Klein, Cornelia, Kojima, Seiji, Stary, Jan, Trebo, Monika, Zecca, Marco, Gelb, Bruce D., Tartaglia, Marco, Loh, Mignon L.
Publicado em 2005

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia

Por Archambeault, Sophie, Flores, Nikki J., Yoshimi, Ayami, Kratz, Christian P., Reising, Miriam, Fischer, Alexandra, Noellke, Peter, Locatelli, Franco, Sedlacek, Petr, Flotho, Christian, Zecca, Marco, Emanuel, Peter D., Castleberry, Robert P., Niemeyer, Charlotte M., Bader, Peter, Loh, Mignon L.
Publicado em 2008

Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

Por Baker, David L., Schmidt, Mary L., Cohn, Susan L., Maris, John M., London, Wendy B., Buxton, Allen, Stram, Daniel, Castleberry, Robert P., Shimada, Hiroyuki, Sandler, Anthony, Shamberger, Robert C., Look, A. Thomas, Reynolds, C. Patrick, Seeger, Robert C., Matthay, Katherine K.
Publicado em 2010

Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children’s Oncology Group

Por Stieglitz, Elliot, Ward, Ashley F., Gerbing, Robert B., Alonzo, Todd A., Arceci, Robert J., Liu, Y. Lucy, Emanuel, Peter D., Widemann, Brigitte C., Cheng, Jennifer W., Jayaprakash, Nalini, Balis, Frank M., Castleberry, Robert P., Bunin, Nancy J., Loh, Mignon L., Cooper, Todd M.
Publicado no Pediatr Blood Cancer (2014)